BioCentury | Jan 25, 2019
Politics, Policy & Law
101 problems with patent eligibility
...other diagnostic companies. Kevin Noonan, a partner at McDonnell Boehnen Hulbert & Berghoff LLP, cited Sequenom Inc....
...for Section 101 damage. In the 2015 Ariosa Diagnostics Inc. v. Sequenom Inc. case before CAFC, Sequenom’s...
...as patent ineligible. The next year, Sequenom was acquired by Laboratory Corp. of America Holdings. Sequenom’s...
...for Section 101 damage. In the 2015 Ariosa Diagnostics Inc. v. Sequenom Inc. case before CAFC, Sequenom’s...
...as patent ineligible. The next year, Sequenom was acquired by Laboratory Corp. of America Holdings. Sequenom’s...